Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023 Nov;20(11):733.
doi: 10.1038/s41571-023-00817-3.

Early promising results with the novel KRASG12C inhibitor divarasib

Affiliations
Comment

Early promising results with the novel KRASG12C inhibitor divarasib

Diana Romero. Nat Rev Clin Oncol. 2023 Nov.
No abstract available

PubMed Disclaimer

Comment on

  • Single-Agent Divarasib (GDC-6036) in Solid Tumors with a KRAS G12C Mutation.
    Sacher A, LoRusso P, Patel MR, Miller WH Jr, Garralda E, Forster MD, Santoro A, Falcon A, Kim TW, Paz-Ares L, Bowyer S, de Miguel M, Han SW, Krebs MG, Lee JS, Cheng ML, Arbour K, Massarelli E, Choi Y, Shi Z, Mandlekar S, Lin MT, Royer-Joo S, Chang J, Dharia NV, Schutzman JL, Desai J; GO42144 Investigator and Study Group. Sacher A, et al. N Engl J Med. 2023 Aug 24;389(8):710-721. doi: 10.1056/NEJMoa2303810. N Engl J Med. 2023. PMID: 37611121 Clinical Trial.

References

Original article
    1. Sacher, A. et al. Single-agent divarasib (GDC-6036) in solid tumors with a KRAS G12C mutation. New Engl. J. Med. 389, 710–721 (2023) - DOI - PubMed

LinkOut - more resources